Apple has urged a California federal judge to dismiss Masimo’s request for nearly $243 million in interest, following a $634 million patent jury verdict related to the Apple Watch’s heart rate technology. According to Apple, the additional damages sought would result in an “enormous windfall,” rendering the total damages award disproportionate. The Cupertino-based tech giant’s response comes amid ongoing legal battles concerning the health-monitoring features integrated into their popular wearable device, the Apple Watch.
This patent dispute centers on Masimo’s allegations that Apple unlawfully appropriated its patented technology, particularly the sensor technology that measures heart rate. In April, a jury concluded that some Apple Watches infringed two of Masimo’s patents. As reported by Law360, this recent pushback from Apple highlights its stance that the initial damages are already substantial, given the nature of the patent claims.
In a broader industry context, this case illustrates the increasing intersection between consumer technology and healthcare, with significant financial implications. Apple is not alone in this space; numerous tech companies are investing heavily in health-monitoring capabilities, recognizing the potential for growth in health technology markets.
Reuters notes that Apple’s legal strategy focuses on minimizing the financial implications of these legal challenges, challenging both the merit of Masimo’s claims and the financial calculations underpinning them.
The case is a critical reminder for corporations regarding patent strategy, particularly in sectors where technical innovation is rapid, and intellectual property disputes can have substantial financial repercussions.